GPD1L ‐Mediated Glycerophospholipid Metabolism Dysfunction in Women With Diminished Ovarian Reserve: Insights From Pseudotargeted Metabolomic Analysis of Follicular Fluid
Cell Proliferation · 2025-09 · 58 (9)
DOI: 10.1111/cpr.70024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 20.03.2025. Verfasst von Jiaqi Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Reproductive Medicine, Beijing Obstetrics and Gynecology Hospital, Beijing Maternal and Child Health Care Hospital, Capital Medic…. Hauptthemen laut MEDLINE: Follicular Fluid, Ovarian Reserve, Glycerophospholipids. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Diminished ovarian reserve (DOR) is a pathological condition characterised by reduced ovarian function, which refers to the decreased quality and quantity of oocytes, potentially causing female infertility and various health issues. Follicular fluid (FF) serves as the microenvironment for follicular development and oocyte maturation, gaining an in‐depth understanding of the metabolic state of FF will help us uncover the key biological processes involved in ovarian aging, while the specific underlying pathogenic mechanisms are not fully understood. In this study, we utilised pseudotargeted metabolomic analysis of FF to reveal the glycerophospholipid metabolism dysfunction mediated by GPD1L in DOR patients. We also found that GPD1L was downregulated in granulosa cells (GCs) of DOR patients, resulting in increased cell apoptosis and mitochondrial dysfunction. Moreover, our results demonstrated that the downregulated expression of GPD1L could induce follicular atresia and impair oocyte quality in mouse ovaries. Altogether, our research suggested that GPD1L in GCs and the key metabolites in the glycerophospholipid metabolism pathway could potentially act as novel biomarkers of DOR diagnosis, paving the way for a new theoretical basis for understanding the pathogenesis of DOR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Reproductive Medicine, Beijing Obstetrics and Gynecology Hospital, Beijing Maternal and Child Health Care Hospital, Capital Medical University, Beijing, China.
- Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
- Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.
- University of Chinese Academy of Sciences, Beijing, China.
- Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China.
ORCID-Profile: Long Yan, Xiaokui Yang
Förderung
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Wu, J., Zhao, X., Fang, Y., Wang, C., Tian, Y., Tu, W., Wu, Q., Yan, L., & Yang, X. (2025). GPD1L ‐Mediated Glycerophospholipid Metabolism Dysfunction in Women With Diminished Ovarian Reserve: Insights From Pseudotargeted Metabolomic Analysis of Follicular Fluid. Cell Proliferation, 58(9). https://doi.org/10.1111/cpr.70024
Vancouver
Wu J, Zhao X, Fang Y, Wang C, Tian Y, Tu W, et al. GPD1L ‐Mediated Glycerophospholipid Metabolism Dysfunction in Women With Diminished Ovarian Reserve: Insights From Pseudotargeted Metabolomic Analysis of Follicular Fluid. Cell Proliferation. 2025;58(9). doi:10.1111/cpr.70024
BibTeX
@article{Wu2025,
author = {Wu, Jiaqi and Zhao, Xuehan and Fang, Ying and Wang, Cong and Tian, Yichang and Tu, Wan and Wu, Qiqian and Yan, Long and Yang, Xiaokui},
title = {GPD1L ‐Mediated Glycerophospholipid Metabolism Dysfunction in Women With Diminished Ovarian Reserve: Insights From Pseudotargeted Metabolomic Analysis of Follicular Fluid},
journal = {Cell Proliferation},
year = {2025},
volume = {58},
number = {9},
doi = {10.1111/cpr.70024}
}
EUVIMED